We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID‐19 and resource‐limited settings‐role of subcutaneous insulin.
- Authors
Priyambada, Leena; Wolfsdorf, Joseph I.; Brink, Stuart J.; Fritsch, Maria; Codner, Ethel; Donaghue, Kim C.; Craig, Maria E.
- Abstract
The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA in young people. Intravenous (IV) infusion of insulin remains the treatment of choice for treating DKA; however, the policy of many hospitals around the world requires admission to an intensive care unit (ICU) for IV insulin infusion. During the coronavirus 2019 (COVID‐19) pandemic or other settings where intensive care resources are limited, ICU services may need to be prioritized or may not be appropriate due to risk of transmission of infection to young people with type 1 or type 2 diabetes. The aim of this guideline, which should be used in conjunction with the ISPAD 2018 guidelines, is to ensure that young individuals with DKA receive management according to best evidence in the context of limited ICU resources. Specifically, this guideline summarizes evidence for the role of subcutaneous insulin in treatment of uncomplicated mild to moderate DKA in young people and may be implemented if administration of IV insulin is not an option.
- Subjects
PREVENTION of infectious disease transmission; SUBCUTANEOUS injections; DIABETIC acidosis; HEALTH facility administration; HOSPITAL admission &; discharge; INSULIN; INTENSIVE care units; INTRAVENOUS therapy; MEDICAL protocols; PATIENTS; PEDIATRICS; DISEASE management; COVID-19 pandemic
- Publication
Pediatric Diabetes, 2020, Vol 21, Issue 8, p1394
- ISSN
1399-543X
- Publication type
Article
- DOI
10.1111/pedi.13118